Publication | Closed Access

The metabotropic glutamate receptor 5 antagonist MPEP and the mGluR2 agonist LY379268 modify disease progression in a transgenic mouse model of Huntington's disease

GeneticsExperimental NeuropathologyNeuropharmacologyAntagonist MpepNeurologyNeuroscienceNeurodegenerationTransgenic Mouse ModelDopamineMedicineMolecular Neurobiology